Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 18Papillomavirus Infections 14Uterine Cervical Dysplasia 6Condylomata Acuminata 6Anus Neoplasms 4Vulvar Neoplasms 2Whooping Cough 1Virus Diseases 1Vaginal Neoplasms 1Tetanus 1Persistent Infection 1Neoplasms, Glandular and Epithelial 1Meningitis 1Lung Neoplasms 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1HIV Infections 1Diphtheria 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Vaccines 1Tetanus Toxoid 1Pneumococcal Vaccines 1Papillomavirus Vaccines 1Measles-Mumps-Rubella Vaccine 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Heptavalent Pneumococcal Conjugate Vaccine 1Hepatitis B Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Whooping Cough × Papillomavirus Vaccines × Clear all
NCT00325130 2015-03-12

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Merck Sharp & Dohme LLC

Phase 3 Completed
1,042 enrolled 26 charts

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

Data powered by HemOnc (CC BY 4.0) Colophon âš¡